It's almost impossible for them to figure out how much alternative care substitutes for conventional care. Are people who use these therapies seeing their physicians for the same disorder? Are they seeing them less? Are they getting fewer tests?
These companies are not expecting to cut costs, they're offering these benefits just to cut down on turnover, attract people and keep them.
If the evidence mounts about the effectiveness of these therapies, it will add to the momentum. But somebody needs to resolve the turnover problem and more companies need to see actual savings.
